IRadimed Announces Uplisting To The Nasdaq Global Market, Effective June 14, 2024
Portfolio Pulse from Benzinga Newsdesk
IRadimed Corporation (NASDAQ:IRMD) announced that its common stock will uplist to the Nasdaq Global Market, effective June 14, 2024. The stock will continue to trade under the ticker symbol 'IRMD'.

June 07, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IRadimed Corporation's uplisting to the Nasdaq Global Market is likely to increase its visibility and attract more institutional investors, potentially boosting its stock price in the short term.
Uplisting to the Nasdaq Global Market generally increases a company's visibility and credibility, attracting more institutional investors. This can lead to increased demand for the stock, potentially driving up the price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100